ABSTRACT
PURPOSE: The purpose of the present study is to carry out radiation shielding calculations to find out adequate thicknesses of protective barriers such as walls and ceiling based on minimum space required to house helical tomotherapy unit. This study also aim to derive expression for use factor and estimation of patient workload for tomotherapy facility for optimizing radiation shielding requirements. MATERIALS AND METHODS: The basic definitions and formulae given in NCRP/IAEA reports were referred and modified for tomotherapy machine to calculate optimized shielding thicknesses requirements. Workload is estimated based on observations of patient treatments on tomotherapy machine and analysis of their treatment plan data. A mathematical expression is derived for calculating use factor in terms of beam divergence angle at source corresponding to field length, angle of source rotation about isocenter, and distance of primary barrier from isocenter. Radiation shielding requirement of protective barriers such as walls and ceiling of helical tomotherapy vault is calculated based on minimum room dimensions as specified by the manufacturer, permissible dose limit (s), and values of optimizing parameters such as workload, use factor etc. for tomotherapy machine. RESULTS: Using derived mathematical expression for use factor in this study, it was found that value of use factor varies with distance of primary barrier from isocenter and its value was found to be 0.093 for given minimum room dimensions. Radiation shielding requirements for protective barriers (walls/ceiling, etc.) were arrived and reported in this paper. CONCLUSIONS: A typical helical tomotherapy vault design is proposed based on the calculated shielding thicknesses of protective barriers. Further, it is also concluded that tomotherapy machine can be installed in a vault designed for 6 MV conventional linear accelerator with minor modification.
ABSTRACT
BACKGROUND: Infections are the most important cause of mortality in patients with high-risk febrile neutropenia. Emergence of multi-drug resistant organisms (MDROs) has become a major challenge for hemato-oncologists. Knowledge of the prevalent organisms and their antimicrobial sensitivity can help deciding the empirical therapy at individual centers and allows timely measures to reduce the risk of antimicrobial resistance. AIMS: To evaluate the frequency of bacterial isolates from all the samples and the pattern of bacterial bloodstream infections and incidence of MDROs. SETTINGS AND DESIGN: This is a retrospective analysis from a tertiary care cancer center. MATERIALS AND METHODS: From January to June 2014 information on all the samples received in Department of Microbiology was collected retrospectively. The data from samples collected from patients with hematological cancers were analyzed for types of bacterial isolates and antimicrobial sensitivity. RESULTS: A total of 739 isolates were identified with 67.9% of isolates being Gram-negative. The predominant Gram-negative organisms were Escherichia coli, Psuedomonas spp. and Klebsiella spp. Among the bacterial bloodstream infections, 66% were Gram-negative isolates. MDROs constituted 22% of all isolates in blood cultures. Incidence of resistant Gram-positive organisms was low in the present dataset (methicillin resistant Staphylococcus aureus and vancomycin-resistant enterococci-1.3%). CONCLUSIONS: The analysis reconfirms the Gram-negative organisms as the predominant pathogens in bacteremia seen in patients with hematological cancers. The high frequency of multi-drug resistance in the dataset calls for the need of emergency measures to curtail further development and propagation of resistant organisms.
